Safety and Efficacy of Ga68-IAC PET/CT for Diagnosis and Clinical Management in Metastatic Breast Cancer Patients

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 30, 2025

Primary Completion Date

May 30, 2027

Study Completion Date

August 30, 2027

Conditions
Angiogenic Breast Cancer
Interventions
DIAGNOSTIC_TEST

Ga-68-IAC

Clinical management and diagnosis of Metastatic Breast Cancer.

Trial Locations (3)

Unknown

Postgraduate Institute of Medical and Research, Chandigarh

All India Institute of Medical Sciences, New Delhi

University of Witwatersrand, Johannesburg

All Listed Sponsors
collaborator

All India Institute of Medical Sciences

OTHER

collaborator

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

collaborator

University of Witwatersrand, South Africa

OTHER

collaborator

US Department of Veterans Affairs

FED

lead

Advanced Imaging Projects, LLC

INDUSTRY